Sep 13, 2023 8:30am EDT Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th
Sep 06, 2023 9:00am EDT Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th
Sep 05, 2023 9:00am EDT Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th
Aug 10, 2023 8:00am EDT Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 19, 2023 9:00am EDT Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
Jul 10, 2023 8:30am EDT Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11
Jun 28, 2023 8:30am EDT Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
Jun 27, 2023 8:30am EDT Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium
Jun 26, 2023 8:30am EDT Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium
